International Stem Cell Corp (ISCO)
0.1026
+0.04
(+68.00%)
USD |
OTCM |
Mar 27, 16:00
International Stem Cell Cash from Investing (TTM): -0.083M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -0.083M |
June 30, 2023 | -0.073M |
March 31, 2023 | -0.026M |
December 31, 2022 | -0.011M |
September 30, 2022 | -0.026M |
June 30, 2022 | -0.043M |
March 31, 2022 | -0.043M |
December 31, 2021 | -0.045M |
September 30, 2021 | -0.053M |
June 30, 2021 | -0.044M |
March 31, 2021 | -0.069M |
December 31, 2020 | -0.108M |
September 30, 2020 | -0.18M |
June 30, 2020 | -0.273M |
March 31, 2020 | -0.416M |
December 31, 2019 | -0.494M |
September 30, 2019 | -0.528M |
June 30, 2019 | -0.556M |
March 31, 2019 | -0.579M |
December 31, 2018 | -0.661M |
September 30, 2018 | -0.742M |
June 30, 2018 | -0.777M |
March 31, 2018 | -0.902M |
December 31, 2017 | -0.864M |
September 30, 2017 | -0.834M |
Date | Value |
---|---|
June 30, 2017 | -0.896M |
March 31, 2017 | -0.885M |
December 31, 2016 | -0.943M |
September 30, 2016 | -0.968M |
June 30, 2016 | -0.906M |
March 31, 2016 | -0.792M |
December 31, 2015 | -0.738M |
September 30, 2015 | -0.771M |
June 30, 2015 | -0.791M |
March 31, 2015 | -0.998M |
December 31, 2014 | -0.987M |
September 30, 2014 | -1.128M |
June 30, 2014 | -1.081M |
March 31, 2014 | -0.884M |
December 31, 2013 | -0.896M |
September 30, 2013 | -0.67M |
June 30, 2013 | -0.71M |
March 31, 2013 | -0.738M |
December 31, 2012 | -0.786M |
September 30, 2012 | -0.762M |
June 30, 2012 | -0.872M |
March 31, 2012 | -0.843M |
December 31, 2011 | -0.941M |
September 30, 2011 | -0.933M |
June 30, 2011 | -0.7845M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.579M
Minimum
Mar 2019
-0.011M
Maximum
Dec 2022
-0.1921M
Average
-0.073M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
AIM ImmunoTech Inc | 2.745M |
Perspective Therapeutics Inc | -10.70M |
Protalix BioTherapeutics Inc | -16.71M |
Electromed Inc | -1.219M |
Armata Pharmaceuticals Inc | -8.134M |